SCWorx (STU:4R80) Notes Receivable: €0.00 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:4R80 SCWorx Corp STU:4R80
42 GF Score
Price €1.26
GF Value €3.58
! 4 Warning Signs
View Full Analysis

What is SCWorx Notes Receivable?

SCWorx STU:4R80 42 Notes Receivable is €0.00 Mil as of Mar. 2026. GuruFocus rates STU:4R80 with a GF Score™ of 42/100 and a GF Value™ of €3.58. The stock has 4 warning signs investors should review.

SCWorx's Notes Receivable for the quarter that ended in Mar. 2026 was €0.00 Mil.

SCWorx Notes Receivable Historical Data

* Premium members only.

The historical data trend for SCWorx's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SCWorx Notes Receivable Chart

SCWorx Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

SCWorx Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
STU:4R80
42GF Score
SCWorx Corp STU:4R80
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SCWorx Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of €0.00 Mil mean?
SCWorx (STU:4R80) has a Notes Receivable of €0.00 Mil as of Mar. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on SCWorx and its competitors.
Is SCWorx's Notes Receivable too high?
SCWorx's current Notes Receivable is €0.00 Mil. Overall, SCWorx has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does SCWorx's Notes Receivable compare to FOXO and LGMK?
SCWorx's Notes Receivable of €0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Healthcare Providers & Services company?
A good Notes Receivable depends on the Healthcare Providers & Services industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on SCWorx and its competitors. SCWorx's current Notes Receivable is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SCWorx stock overvalued right now?
SCWorx (STU:4R80) has a current Notes Receivable of €0.00 Mil. The stock's GF Value™ is €3.58, compared to a current price of €1.26 — trading 64.8% below its estimated fair value. The current Notes Receivable is €0.00 Mil. SCWorx's overall GF Score™ is 42/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For SCWorx (STU:4R80), the current Notes Receivable is €0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SCWorx (STU:4R80) Overvalued in 2026?

Based on GuruFocus' analysis, SCWorx stock appears to be undervalued. The current stock price of €1.26 is trading 64.8% below its estimated GF Value™ of €3.58.

Key valuation signals for STU:4R80:

  • Notes Receivable: €0.00 Mil
  • GF Value™: €3.58 vs. price of €1.26 (64.8% below fair value)
  • GF Score™: 42/100 with 4 warning signs

No single metric tells the full story. See the STU:4R80 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SCWorx Business Description

Other Exchanges WORX:USA
Address 35 Village Road, Suite 100, Middleton, MA, USA, 01949
SCWorx Corp has developed and markets health information technology solutions and associated services that improve healthcare processes and information flow within hospitals. Its software platform enables healthcare providers to simplify, repair, and organize its data, allows the data to be utilized across multiple internal software applications and provides the basis for sophisticated data analytics. The company's solutions are designed to improve the flow of information quickly and accurately between the existing supply chain, electronic medical records, clinical systems, and patient billing functions. It operates in a single segment - health information technology solutions and services, located in a single geographic location - the United States.
42GF Score

Get the complete analysis for STU:4R80

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.26
Price
€3.58
GF Value